| 1 |
Zhang L, Zhai BZ, Wu YJ, Wang Y. Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment. Drug Deliv 2023;30:1-18. [PMID: 36597205 DOI: 10.1080/10717544.2022.2144541] [Reference Citation Analysis]
|
| 2 |
Parveen N, Abourehab MA, Shukla R, Thanikachalam PV, Jain GK, Kesharwani P. Immunoliposomes as an emerging nanocarrier for breast cancer therapy. European Polymer Journal 2023;184:111781. [DOI: 10.1016/j.eurpolymj.2022.111781] [Reference Citation Analysis]
|
| 3 |
Pradhan R, Dey A, Taliyan R, Puri A, Kharavtekar S, Dubey SK. Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer. Pharmaceutics 2023;15. [PMID: 36678877 DOI: 10.3390/pharmaceutics15010246] [Reference Citation Analysis]
|
| 4 |
Sheikh A, Kaur H, Abourehab MA, Alam MS, Kesharwani P. Aptamer-functionalized dendrimers for targeted cancer therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 2023. [DOI: 10.1016/b978-0-323-85881-6.00027-0] [Reference Citation Analysis]
|
| 5 |
Rout SR, Kenguva G, Sharma D, Sahebkar A, Aeri V, Kesharwani P, Dandela R. Gene therapy using PLGA nanoparticles. Poly(Lactic-Co-glycolic Acid) (PLGA) Nanoparticles for Drug Delivery 2023. [DOI: 10.1016/b978-0-323-91215-0.00009-1] [Reference Citation Analysis]
|
| 6 |
Yang F, He Q, Dai X, Zhang X, Song D. The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies. Front Pharmacol 2023;14:1143102. [PMID: 36909177 DOI: 10.3389/fphar.2023.1143102] [Reference Citation Analysis]
|
| 7 |
Dey A, Kesharwani P, Dubey SK. Actively targeted nanoparticles in photodynamic therapy. Nanomaterials for Photodynamic Therapy 2023. [DOI: 10.1016/b978-0-323-85595-2.00014-1] [Reference Citation Analysis]
|
| 8 |
Kesharwani P, Chadar R, Shukla R, Jain GK, Aggarwal G, Abourehab MAS, Sahebkar A. Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics. J Biomater Sci Polym Ed 2022;33:2433-71. [PMID: 35848467 DOI: 10.1080/09205063.2022.2103627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Li D, Li J, Wang S, Teng W, Wang Q. Combined Self-Assembled iRGD Polymersomes for Effective Targeted siRNA Anti-Tumor Therapy. IJN 2022;Volume 17:5679-5696. [DOI: 10.2147/ijn.s383862] [Reference Citation Analysis]
|
| 10 |
Ali AA, Al-Othman A, Al-Sayah M. Multifunctional stimuli-responsive hybrid nanogels for cancer therapy: Current status and challenges. J Control Release 2022:S0168-3659(22)00628-9. [PMID: 36170926 DOI: 10.1016/j.jconrel.2022.09.033] [Reference Citation Analysis]
|
| 11 |
Shaw S, Singh P, Mishra R, Singh R, Nayak R, Bose S. Cancer therapeutics strategy using nano-carrier mediated natural drugs. Journal of Achievements in Materials and Manufacturing Engineering 2022;114:32-41. [DOI: 10.5604/01.3001.0016.1481] [Reference Citation Analysis]
|
| 12 |
Jana P, Dev A. Carbon quantum dots: A promising nanocarrier for bioimaging and drug delivery in cancer. Materials Today Communications 2022;32:104068. [DOI: 10.1016/j.mtcomm.2022.104068] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Li Y, Ruan S, Guo J, He Z, Xia Q, Wu T, Wang Z, Li Z, Hu H, Jing Q, Hou X, He Y, Zhang B, Feng N, Zhang Y. B16F10 Cell Membrane-Based Nanovesicles for Melanoma Therapy Are Superior to Hyaluronic Acid-Modified Nanocarriers. Mol Pharm 2022. [PMID: 35850109 DOI: 10.1021/acs.molpharmaceut.2c00212] [Reference Citation Analysis]
|
| 14 |
Singh N, Handa M, Singh V, Kesharwani P, Shukla R. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 2022;:1-34. [PMID: 35722764 DOI: 10.1080/1061186X.2022.2092741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Kumar Dubey S, Dabholkar N, Narayan Pal U, Singhvi G, Kumar Sharma N, Puri A, Kesharwani P. Emerging innovations in cold plasma therapy against cancer: a paradigm shift. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.05.014] [Reference Citation Analysis]
|
| 16 |
Sheikh A, Md S, Alhakamy NA, Kesharwani P. Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Rezayan AH, Kheirjou S, Edrisi M, Shafiee Ardestani M, Alvandi H. A Modified PEG-Fe3O4 Magnetic Nanoparticles Conjugated with D( +)Glucosamine (DG): MRI Contrast Agent. J Inorg Organomet Polym. [DOI: 10.1007/s10904-022-02253-9] [Reference Citation Analysis]
|
| 18 |
Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease. J Control Release 2022:S0168-3659(22)00058-X. [PMID: 35114208 DOI: 10.1016/j.jconrel.2022.01.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Singh V, Md S, Alhakamy NA, Kesharwani P. Taxanes loaded polymersomes as an emerging polymeric nanocarrier for cancer therapy. European Polymer Journal 2022;162:110883. [DOI: 10.1016/j.eurpolymj.2021.110883] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 20 |
Dubey SK, Bhatt T, Agrawal M, Saha RN, Saraf S, Saraf S, Alexander A. Application of chitosan modified nanocarriers in breast cancer. Int J Biol Macromol 2022;194:521-38. [PMID: 34822820 DOI: 10.1016/j.ijbiomac.2021.11.095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 21 |
Nadaf A, Gupta A, Hasan N, Fauziya, Ahmad S, Kesharwani P, Ahmad FJ. Recent update on electrospinning and electrospun nanofibers: current trends and their applications. RSC Adv 2022;12:23808-28. [DOI: 10.1039/d2ra02864f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Sheikh A, Md S, Kesharwani P. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomed Pharmacother 2021;146:112530. [PMID: 34915416 DOI: 10.1016/j.biopha.2021.112530] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
